Zynerba Pharmaceuticals (ZYNE)

[Leonard McKinley]

It is not completely accurate that zyne has the only therapy for fragile x. OVID has a candidate molecule for fragile x, and I would not under estimate OVID. I suspect that ASD is the even bigger deal for zyne.
It seems likely to me that there has been some serious shorting of zyne in this recent event. That should generate some helpful buying to the price recovery I expect.